Citius Pharmaceuticals Inc (CTXR) stock is lower by -27.62% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 5. CTXR's rank also includes a long-term technical score of 27.
CTXR has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CTXR!
Citius Pharmaceuticals Inc (CTXR) stock has risen 12.82% while the S&P 500 is up 0.22% as of 12:31 PM on Tuesday, Oct 24. CTXR is up $0.09 from the previous closing price of $0.67 on volume of 3,603,865 shares. Over the past year the S&P 500 is higher by 11.30% while CTXR is lower by -27.62%. CTXR lost -$0.21 per share in the over the last 12 months.
Click Here to get the full Stock Report for Citius Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
